1Miyagi Y, Koshikawa N, Yasumitsu H, et al. cDNA cloning and mR- NA expression of a serine proteinase inhibitor secreted by cancer cells: identification as placental protein 5 and tissue factor pathway inhibitor - 2 [ J ]. J Biochem, 1994,116 ( 5 ) :939 - 942. 被引量：1
2Kamei S, Kazama Y, Kuijper JL, et al. Genomic structure and pro- moter activity of the human tissue factor pathway inhibitor - 2 gene [ J ]. Biochim Biophys Acta,2001,1517 ( 3 ) : 430 - 435. 被引量：1
4Rao CN, Mohanam S, Puppala A, at al. Regulation of ProMMP - 1 and ProMMP -3 activation by tissue factor pathway inhibitor -2/ma- trix- associated serine protease inhibitor [ J ]. Biochem Biophys Res Commun, 1999,255 ( 1 ) :94 - 98. 被引量：1
5Herman MP, Sukhova GK, Kisiel W, et al. Tissue factor pathway in- hibitor - 2 is a novel inhibitor of matrix metalloproteinases with impli- cations for atherosclerosis [ J ]. J Clin Invest, 2001,107 ( 9 ) : 1117 - 1126. 被引量：1
6Du X, Chand HS, Kisiel W. Human tissue factor pathway inhibitor - 2 does not bind or inhibit activated matrix metaloproteinase - 1 [ J ]. Biochim Biophys Acta,2003,1621 ( 3 ) :242 - 245. 被引量：1
7Chand HS, Du X, Ma D, et al. The effect of human tissue factor pathway inhibitor - 2 on the growth and metastasis of fibrosarcoma tumors in athymic mice [ J ]. Blood,2004,103 ( 3 ) : 1069 - 1077. 被引量：1
8Rollin J, Regina S, Vourch P, et al. Influence of MMP -2 and MMP -9 promoter polymorphisms on gene expression and clinical outcome of non - small cell lung cancer [ J ]. Lung Cancer,2007,56 ( 2 ) : 273 - 280. 被引量：1
4Glahn J. Genetic variations in the human TFPI-2 gene and its promoter region by denaturing high performance liquid chmmatogrphy [ J ]. Thremb Res,2004,113 (2) :341-343. 被引量：1
5Hube F, Reverdiau P, Ioehmann S,et al. Computer model of the interaction of human TFPI-2 Kunitz type sefine protease inhibitor with human plasmin [ J ]. Thromb Res ,2003,111 ( 1 ) : 197-198. 被引量：1
6Chand HS, Schmidt AE, Bajaj SP, et al. Structure-function analysis of the reactive site in the first kunitz-type domain oihuman tissue factor pathway inhibitor-2 [ J ]. J Bid Chem, 2004, 279 ( 17 ) : 17500-17507. 被引量：1
7Liu YY,Stack SM,Lakka SS,et al. Matrix loeallotion of tissue factorpathway inhibitor-2/matrix) associated serine protease inhibitor (TFPI-2/MSPI) involves Arglnine mediated ionie interactions with heparin and dermatan sulfate: Heparin aceelerates the activity of TFPI-2/MSPI toward plasmin [ J ]. Arch Bioehem Biophys, 1999, 370( 1 ) :112-118. 被引量：1
8Hub6 F, Reverdiau P, Iochmann S,et al. Characterization and funetional analysis of TFPI-2 gene promoter in a human chorioearcinomaeell line[J]. Thromb Res,2003,109(2) :207-215. 被引量：1
9Esteller M. Aberrant DNA mcthylation as a cancer inducing mechanism [ J ]. Annu Rev Pharmacol Toxicol, 2005,45 (4) : 629 -656. 被引量：1
10Miyagi Y, Koshikawa N, Yasumtisu H, et al. Cdna and Mrna expression of a serine proteinase secreted by cancer cells : indentification as plas protein 5 and tissue factor pathwayinhibitor-2 [ J ]. Biochem, 1994,116 (4) :939-942. 被引量：1
